@±¸±Û Å©·Ò Ç÷¡½Ã(Adobe Flash Player) Â÷´Ü ÇØÁ¦ ÇÏ´Â ¹æ¹ý!!Âü°í
ÄÄÇ»ÅÍ¿¡¼ ChromeÀ» ¿±´Ï´Ù.
¿À¸¥ÂÊ »ó´Ü¿¡¼ ´õº¸±â ´õº¸±â ´ÙÀ½ ¼³Á¤À» Ŭ¸¯ÇÕ´Ï´Ù.
ÇÏ´Ü¿¡¼ °í±ÞÀ» Ŭ¸¯ÇÕ´Ï´Ù.
'°³ÀÎÁ¤º¸ ¹× º¸¾È'¿¡¼ »çÀÌÆ® ¼³Á¤À» Ŭ¸¯ÇÕ´Ï´Ù.
Flash¸¦ Ŭ¸¯ÇÕ´Ï´Ù.
»ó´Ü¿¡¼ »çÀÌÆ®ÀÇ Ç÷¡½Ã ½ÇÇà Â÷´Ü(±ÇÀå)À» »ç¿ë ÁßÁöÇÕ´Ï´Ù.
@¼³Ä¡ ¹®Á¦ | Flash Player | Windows 7 ÀÌÇÏ....Adobe Áö¿ø °Ë»ö
Àû¿ë ´ë»ó: Flash Player....ÃÖÁ¾ °Ô½ÃÀÏ: 2019³â 6¿ù 17ÀÏ
ÀÌ ´Ü°èº° ¾È³»¼¸¦ »ç¿ëÇÏ¿© Windows 7 ÀÌÇÏ ½Ã½ºÅÛ¿¡¼ÀÇ Adobe Flash Player ¼³Ä¡ ¹®Á¦¸¦ ÇØ°áÇϽʽÿÀ. Adobe Flash Player ¹®Á¦¸¦ ÇØ°áÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â À¯¿ëÇÑ ¸®¼Ò½º ¸µÅ©¸¦ ãÀ¸½Ê½Ã¿À.
Adobe Flash Player ¼³Ä¡¿¡ ¹®Á¦°¡ ÀÖ½À´Ï±î? ¹®Á¦¸¦ ÆľÇÇÏ°í ÇØ´ç ÇØ°á¹æ¹ýÀ» ½ÃµµÇØ º¸½Ê½Ã¿À.
1. ÄÄÇ»ÅÍ¿¡ Flash Player°¡ ÀÌ¹Ì ¼³Ä¡µÇ¾î ÀÖ´ÂÁö È®ÀÎÇß½À´Ï±î? [Áö±ÝÈ®ÀÎ]Ŭ¸¯
2. ºê¶ó¿ìÀú¸¦ ´ÝÀ¸¶ó´Â ¸Þ½ÃÁö°¡ Ç¥½ÃµË´Ï±î?
Internet Explorer¿¡¼´Â ¼³Ä¡¸¦ °è¼ÓÇÏ·Á¸é ¼³Ä¡ ÇÁ·Î±×·¥¿¡¼ ºê¶ó¿ìÀú¸¦ ´Ý¾Æ¾ß ÇÕ´Ï´Ù.
[´ÙÀ½ Áöħ..Ŭ¸¯]À» µû¸£½Ê½Ã¿À.
¶ÇÇÑ, ÀÀ¿ë ÇÁ·Î±×·¥¿¡¼ ÀÌ¹Ì ¼³Ä¡µÇ¾î ÀÖ´Â Flash Player ¹öÀüÀ» »ç¿ë ÁßÀÎ °æ¿ì¿¡´Â Flash Player ¼³Ä¡ ÇÁ·Î±×·¥ÀÌ Á¦´ë·Î ½ÇÇàµÇÁö ¾Ê½À´Ï´Ù. ÀÌ·¯ÇÑ °æ¿ì ¿·Á ÀÖ´Â ÀÀ¿ë ÇÁ·Î±×·¥À» ¸ðµÎ ´Ý°í ´Ù½Ã ½ÃµµÇϽʽÿÀ.
3. ºê¶ó¿ìÀú¿¡ Flash Player°¡ È°¼ºÈµÇ¾î ÀÖ´ÂÁö È®ÀÎÇß½À´Ï±î?
Internet ExplorerÀÇ °æ¿ì Internet Explorer¿¡ ´ëÇØ Flash Player È°¼ºÈ¸¦ ÂüÁ¶ÇϽʽÿÀ.
Firefox(¸ðµç OS)ÀÇ °æ¿ì Firefox¿¡ ´ëÇØ Flash Player È°¼ºÈ¸¦ ÂüÁ¶ÇϽʽÿÀ.
Mac OS¿¡ ÀÖ´Â SafariÀÇ °æ¿ì Safari¿¡ ´ëÇØ Flash Player È°¼ºÈ¸¦ ÂüÁ¶ÇϽʽÿÀ.
Google ChromeÀÇ °æ¿ì Chrome¿¡ ´ëÇØ Flash Player È°¼ºÈ¸¦ ÂüÁ¶ÇϽʽÿÀ.
OperaÀÇ °æ¿ì Opera¿¡ ´ëÇØ Flash Player È°¼ºÈ¸¦ ÂüÁ¶ÇϽʽÿÀ.
4. ActiveX ¹®Á¦°¡ Æ÷ÇÔµÈ ¿À·ù°¡ Ç¥½ÃµË´Ï±î?
Flash Player°¡ Á¦´ë·Î ÀÛµ¿Çϵµ·Ï ActiveX ÇÊÅ͸µÀ» ºñÈ°¼ºÈÇÕ´Ï´Ù.
IE9, IE10 ¹× IE11¿¡¼ 'ActiveX ÇÊÅ͸µ' ¼³Á¤ ¶Ç´Â ÇØÁ¦ ¹æ¹ýÀ» ÂüÁ¶ÇϽʽÿÀ.
5. ¼³Ä¡ ÇÁ·Î±×·¥¿¡¼ ¼³Ä¡¸¦ ½ÃÀÛÇß½À´Ï±î?
´Ù¿î·Îµå°¡ ¿Ï·áµÇ¸é Flash Player ¼³Ä¡ ÇÁ·Î±×·¥¿¡¼ ¼³Ä¡¸¦ ½ÃÀÛÇ϶ó´Â ¸Þ½ÃÁö¸¦ Ç¥½ÃÇÕ´Ï´Ù. Ç¥½ÃµÇÁö ¾Ê´Â °æ¿ì, Downloads Æú´õ¿¡¼ ¹Ù·Î ¼³Ä¡ ÇÁ·Î±×·¥À» ½ÃÀÛÇÒ ¼ö ÀÖ½À´Ï´Ù.
Flash Player¸¦ ´Ù¿î·ÎµåÇÑ ÈÄ¿¡ ºê¶ó¿ìÀú¸¦ ¸ðµÎ ´Ý½À´Ï´Ù.
Flash Player ¼³Ä¡ ÆÄÀÏÀ» ã½À´Ï´Ù. ´Þ¸® ÁöÁ¤ÇÏÁö ¾ÊÀº ÇÑ ÀÌ ÆÄÀÏÀº Downloads Æú´õ¿¡ ÀúÀåµÇ¾î ÀÖ½À´Ï´Ù.
¼³Ä¡ ÇÁ·Î±×·¥ ÆÄÀÏÀ» µÎ ¹ø Ŭ¸¯ÇÏ¿© Flash Player ¼³Ä¡¸¦ ½ÃÀÛÇÕ´Ï´Ù.
´Ù¿î·ÎµåÇÑ ÆÄÀÏ Ã£±â¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ³»¿ëÀº Microsoft µµ¿ò¸»¿¡¼ ´Ù¿î·ÎµåÇÑ ÆÄÀÏ Ã£±â ¹× À¥¿¡¼ ÆÄÀÏ ´Ù¿î·Îµå¸¦ ÂüÁ¶ÇϽʽÿÀ.
6. ±ÇÇÑ ¹®Á¦°¡ ¹ß»ýÇմϱî?
Flash Player ¼³Ä¡ ÈÄ ÄÄÇ»Å͸¦ ´Ù½Ã ½ÃÀÛÇϱâ Àü±îÁö´Â ¸ðµç °ÍÀÌ Á¦´ë·Î ÀÛµ¿ÇÕ´Ï´Ù. ´Ù½Ã ½ÃÀÛÇÏ°í ³ª¸é À¥ ÆäÀÌÁö¿¡¼ Flash Player¸¦ ´Ù½Ã ¼³Ä¡Ç϶ó´Â ¸Þ½ÃÁö¸¦ Ç¥½ÃÇÕ´Ï´Ù.
Flash Player °ü·Ã Windows ±ÇÇÑ ¹®Á¦¸¦ ÇØ°áÇÏ·Á¸é ¾î¶»°Ô Çմϱî?
7. Flash Player ¼³Ä¡ ÇÁ·Î±×·¥ÀÌ ½ÇÇàµÇÁö ¾Ê½À´Ï±î?
¼³Ä¡ ÇÁ·Î±×·¥ÀÇ µðÁöÅÐ ÀÎÁõ¼(sha256)¿Í ȣȯµÇµµ·Ï ¿î¿µ üÁ¦¸¦ ¾÷µ¥ÀÌÆ®ÇØ¾ß ÇÒ ¼öµµ ÀÖ½À´Ï´Ù. ´ÙÀ½ ¿î¿µ üÁ¦¸¦ ¾÷µ¥ÀÌÆ®ÇØ¾ß ÇÕ´Ï´Ù.
Windows XP ¿î¿µ üÁ¦°¡ Windows XPÀÌ°í ¼ºñ½º ÆÑ 2 ÀÌÇϸ¦ ½ÇÇà ÁßÀÎ °æ¿ì ¼ºñ½º ÆÑ 3À¸·Î ¾÷±×·¹À̵åÇÕ´Ï´Ù.
Windows Vista ¿î¿µ üÁ¦°¡ Windows Vista SP2ÀÎ °æ¿ì Microsoft Áö¿ø¿¡¼ ¿î¿µ üÁ¦¿¡ ¸Â´Â ¾÷µ¥ÀÌÆ®¸¦ ´Ù¿î·ÎµåÇÕ´Ï´Ù.
Windows Server 2008 ¿î¿µ üÁ¦°¡ Windows Server 2008 SP2ÀÎ °æ¿ì Microsoft Áö¿ø¿¡¼ ¿î¿µ üÁ¦¿¡ ¸Â´Â ¾÷µ¥ÀÌÆ®¸¦ ´Ù¿î·ÎµåÇÕ´Ï´Ù.
==¹®Á¦°¡ °è¼Ó ¹ß»ýÇմϱî?
Adobe Flash Player¸¦ ¼³Ä¡ÇÏ´Â µ¥ °è¼Ó ¹®Á¦°¡ ÀÖ´Â °æ¿ì ¼³Ä¡ ÇÁ·Î±×·¥À» ´Ù¿î·ÎµåÇØ º¸½Ê½Ã¿À.
Internet Explorer¿ë Flash Player - ActiveX
Firefox¿ë Flash Player - NPAPI
Opera ¹× Chromium ±â¹Ý ºê¶ó¿ìÀú¿ë Flash Player - PPAPI
Âü°í Ç׸ñ:
Flash Player ¼³Ä¡ ¹× ¾÷µ¥ÀÌÆ® - FAQ
Æ÷·³ÀÇ Àü¹®°¡¿¡°Ô Áú¹®Çϱâ
ÀÚÁÖ ¹ß»ýÇÏ´Â ¹®Á¦
=================
https://selfhacked.com/blog/nad-and-sirt1-their-role-in-chronic-health-issues/
The Importance of SIRT1
SIRT enzymes “turn off” certain genes that promote aging, such as those involved in inflammation, fat synthesis and storage, and managing blood sugar levels.
When proteins are undergoing stress, acetyl groups are added to proteins as a response to changes induced by inflammation and oxidation.
Sirtuins (like SIRT1) remove these acetyl groups to keep the protein in service longer than usual, while simultaneously stabilizing the charge state of the carbon backbone in protein to resist any further changes in their shape. This allows your cellular proteins to live longer and you can save energy on other processes.
Excessive blue light is capable of loosening cytochrome c from the mitochondria, which makes the electron flow less efficient. Red light causes tight binding to remain to cytochrome c in mitochondria and this allows electrons to continue to flow normally to oxygen, which lowers free radical production per oxygen molecule.
SIRT1 powerfully reverses leptin resistance [1].
SIRT1 (and PGC-1a) also make you more sensitive to T3 [2], which is also a problem in CFS – indicated by the fact that people feel cold and have symptoms of low T3 (symptoms that are worse than their numbers reveal).
SIRT1 increases estrogen function (estrogen receptor signaling) [3].
Resveratrol and SIRT1 make you more sensitive to vitamin D – it potentiates the vitamin D receptor (VDR) [4, 5].
SIRT1 inhibits IGF-1 [6].
SIRT1 inhibits mTOR [7].
SIRT1 protects you from nitric oxide. Nitric oxide is damaging but it can also be good. When you have good SIRT1 levels and activity, nitric oxide will stimulate DNA repair genes (via deacetylation of FoxO1). Otherwise, nitric oxide will stimulate genes that will cause the cell to self-destruct [8].
SIRT1 probably overall increases adiponectin release from fat cells. It decreases adiponectin by decreasing PPAR gamma in these cells [9], however, it increases adiponectin by increasing Foxo1 [10, 11, 12].
A reduction in SIRT 1 and SIRT 3 enzymes leads to:
Neurodegeneration in the brain
Vascular inflammation, producing damage to blood vessels that can result in stroke or heart attack
Increased fat storage in the liver, which can lead to fatty liver disease (NAFLD)
Increased fat production and deposition in white adipose tissue, the primary fat storage form found in dangerous belly fat
Insulin resistance, preventing cells from appropriately removing glucose from the blood, producing higher blood sugar levels and leading directly to metabolic syndrome
Fatigue, loss of muscle strength, and fatty infiltration of muscles resulting in reduced fatty acid oxidation (“burning”), thereby depriving muscles of their normal sources of energy.
Molecular Pathways Activated by SIRT1:
SIRT1 causes the activation (by deacetylation) PPAR-alpha, PGC-1a, LXR [13], MAO-A, FOXOs – FOXO1a, Foxo3 [14], UCP2, FGF-21 [15], PXR (overall increase production/activity) [16, 17]. FXR (deacetylation allows to bind with RXR-a, DNA binding, and transactivation activity) [18] – can also inhibit FXR [19].
Deacetylation of Androgen Receptors and Estrogen Receptor-a by SIRT1 causes these hormones to have less cancer growth properties [20].
SIRT1 deacetylates and inhibits NF-kB, STAT3, and MMP9 [21]. SIRT1 deacetylation degrades PER2 [22].
SIRT1 Deacetylates the following other proteins not listed: Hif-1α, Hif-2a, HSF1, Bax, Ku70, b-catenin, E2F1, Myc, TORC2, SREBP, PER2, CLOCK [23].
SIRT1 and The Circadian Rhythm
Not taking care of your circadian rhythm properly is also a root cause of chronic health issues because your circadian rhythm gets deregulated (mainly by not enough sun in the day and too much artificial lighting at night).
The enzyme that makes NAD+ (NAMPT) is under circadian control [24] and is produced by CLOCK and BMAL1.
When your circadian rhythm isn’t working, NAD+ levels are not regulated properly and that means SIRT1 (and SIRT3) isn’t either regulated properly since NAD+ is needed to activate SIRT1 & 3.
SIRT1 regulates the strength (amplitude) and the duration of circadian gene expression in the retina by removing acetyl groups from key circadian clock regulators, such as BMAL1 and PER2.
In aged mice, SIRT1 levels in the SCN (circadian command center) are decreased, as are those of BMAL1 and PER2, causing a longer circadian period, a more disrupted activity pattern, and an inability to adapt to changes in the light entrainment schedule. Young mice lacking brain SIRT1 have similar effects to these aging-dependent circadian changes, whereas mice that overexpress SIRT1 in the brain are protected from the effects of aging (25).
We start getting to feedback loops, where not taking care of your circadian rhythm, hypoxia, excess carbs, and energy imbalance go on to cause an even more deregulated system and you get lower levels of SIRT1.
This is why ALL CFS sufferers that I’ve seen have a messed up circadian rhythm/SCN.
Negatives of SIRT1
The way to look at these negatives is:
Most of the time, biology deals with tradeoffs.
SIRT1 effects are tissue dependent. So even though SIRT1 levels may correlate in one tissue to another, the levels are different.
The cellular environment matters. If SIRT1 is high AND you have certain other genes switched on, then SIRT1 will matter. Otherwise, it won’t. I see this with many other pathways.
SIRT1 is supposed to be cycled in a circadian manner. Chronically high levels could produce a different effect.
Recent studies show that SIRT1 can increase Th17 cells (by deacetylating RORγt), which are inflammatory. Inhibition of SIRT1 suppresses multiple sclerosis [26].
SIRT1 increased the cytokine TNF (in response to LPS), IL-6 and IL-8 in the tissue of patients with rheumatoid arthritis [27].
SIRT1 decreases Nrf2-related gene production since acetylation allows Nrf2 to bind to DNA better and produce antioxidant genes [28].
SIRT1 decreases beta cell proliferation in the pancreas (GLP-1 blocks SIRT1 deacetylation of FoxO1) [29]. Beta cells release insulin, so reduced beta cells can contribute to diabetes, but SIRT1 has many other anti-diabetic actions.
SIRT1 inhibition with nicotinamide is being investigated as an anti-tumor agent because SIRT1 promotes cell survival over apoptosis, which can increase cancer in some ways and also block the ability of chemotherapy to kill cancer [30].
SIRT1 can contribute to cancer by inhibiting DNA repair enzymes (including p53, BRCA1&2, Ku70) and the apoptosis proteins [31].
Specifically, SIRT1 deacetylates p53, which decreases its ability to function as an anti-tumor protein [32].
Since SIRT1 lowers IGF-1 and its receptors, it can cause some downsides to less IGF-1, including less neuroprotection and more likely for your neurons to die [33].
SIRT1 overproduction can impair liver regeneration to a degree [19].
More SIRT1 in CD4+ cells increases Lupus risk [34, 35]
How to Activate SIRT1
Anything that increases NAD+, will increase SIRT1 activity. So I won’t list the ones listed above.
DHA
According to Kruse, SIRT1 and NAD+ provide that fine control through the special properties of DHA.
Increasing DHA is the best way to increase SIRT1 because it works together with it to modulate the immune system and improve your mitochondria.
DHA increases SIRT1 in the blood vessels, which increase Nitric Oxide (eNOS) [36].
DHA decreases macrophage inflammation and inhibits Nf-kB via increasing SIRT1 in macrophages (DHA decreases inflammation via other mechanisms as well) [37]. DHA decreases COX-2 inflammation and insulin resistance also through SIRT1 (in colon cells) [38].
DHA increases SIRT1 in the hippocampus and reverses the cognitive decline in a bunch of disease states. Several epidemiological studies have shown that low blood DHA levels are associated with cognitive deficits in healthy elderly subjects and also in patients suffering from neurodegenerative disorders. Additionally, DHA enhances performance in learning and memory tasks in aged animals, and it also improves cerebral blood flow (which is lacking in CFS sufferers) [39].
DHA supplementation is effective in reversing the reduction of sirt1 levels in rats with mild traumatic brain injury [40].
Ideally, you want to get DHA from fish, but supplements are certainly better than nothing. I use them a little in addition to a lot of seafood.
Cyclic AMP
Cold, forskolin, and adrenaline increase SIRT1 activity by increasing cyclic AMP and this is independent of NAD+ levels [41, 42].
We evolved to have this as a more rapid way to activate metabolism than by slowly increasing NAD+ levels. There are many other benefits to these as well.
Lifestyle:
Cold [41, 42]
Exercise [43]
Sun (Nitric Oxide) [44]
Diet:
Fish/DHA
Fructose – In the liver, fructose increased SIRT1 production and activity [45]
Extra Virgin Olive Oil [46]
Supplements:
Nicotinamide Riboside [47]
Zinc [48]
Nicotine [49]
EGCG/ Tea (cells) [50]
PQQ [51]
Curcumin [52]
Forskolin [41, 42]
Pterostilbene [53]
Vitamin D (active form calcitriol) [54]
Lipoic Acid [55]
Fisetin [56]
Berberine [57]
Epimedium/Icariin [58]
Pau Darco/Beta Lapachone [59]
HMB [60]
Gotu Kola [61]
Grape Seed Extract [62]
Aspirin [63]
Kelp Powder
LLLT (infrared) [64]
Quercetin [65]
Bitter melon [66] – normalizes SIRT1
Pyruvate [16]
Lycopene – metabolite increases SIRT1 production and activity [67]
Butein [56]
Drugs:
Metformin – increases SIRT1 production and activity [68]
Pathways:
Adrenaline [41, 42]
Hydrogen Peroxide [63]
Hydrogen Sulfide [69]
PDE5 inhibitors [44]
PON1 [63], BMAL1 [70], Other: FOXO3a, c-Myc, PARP inhibition
How to Increase NAD+, Which Activates SIRT1
Fasting [71]
Calorie restriction [71]
Exercise [71]
Saunas [72]
Nicotinamide Riboside [47]
Ketosis/β-hydroxybutyrate [73]
Fructose [45]
AMPK activation [74] – AMPK increases SIRT1 activity by increasing cellular NAD+levels (increases NAMPT [68]). SIRT1 activation also stimulates fatty acid oxidation and indirectly activates AMPK.
Pau Darco/Beta Lapachone [59]
Oxaloacetate [75]
Malic acid [76]
Resveratrol [77]
Apigenin [77]
Leucine [77]
Niacinamide – low doses [78]
Lithium inhibits mir-34a, which inhibits NAMPT, the enzyme that makes NAD+ [79, 80] So lithium should technically increase NAMPT and NAD+ by taking the breaks away from its production.
Succinic acid, to a lower degree than malic acid [81]
Tryptophan and Aspartic acid are fuel for NAD+ [82], but we usually get enough dietary amino acids if you eat adequate protein.
SIRT1 Inhibitors
PPAR gamma
Melatonin [31, 83]
IGF-1 [32]
IFNy [84, 85], CIITA [85]
Nicotinamide – at higher doses [86]
CLA (supplement) [87]
Genistein [88]
Trichostatin [89]
SIRT1 Genes
The variation rs12778366 is found in the SIRT1 gene. About 80% of the global population has “TT”, while 18% have CT.
It’s thought that the C allele causes increased gene production of SIRT1 [90].
People with the C allele have an almost 30% reduced risk of dying during an 18-year follow-up study in the general population [91, 92].
TT was at a higher risk for diabetes [93].
People with a C allele had better glucose tolerance indicated by 0.34 mmol/l lower glucose levels [92]. Obese people with the C allele especially had better glucose tolerance [90].
================Ä«½Ã¿ÀAE-1000W ¸ðµ¨......AE-1000W ¸ðµ¨ÀÇ ¼³¸íÀº AE-12000, AE-1400, AE-2000 µî°ú À¯»çÇÑ ¸ðµâÀ̱⶧¹®¿¡ °øÅëÂü°íÇÕ´Ï´Ù....Çѱۼ³¸í¼ ³×À̹ö°Ë»ö : ½Ã°è¿Õ´ÔÀÇ ºí·Î±× https://blog.naver.com/wking2015/221579709764
[[Ä«½Ã¿ÀÀüÀÚ½Ã°è ½Ã°£ Á¶Á¤, ¾Ë¶÷ ¼¼ÆÃ]]...±¸±Û¹ÙÅÁ¿¡¼ ³×À̹ö¸¦ ¿ÀÇÂÇÏ°í ½Ã°è¿Õ´ÔÀÇ ºí·Î±×¸¦ ÀÔ·ÂÇÑ ÈÄ ¿µ»óÀ» º¼ °Í..
---------------------
[[°³¿ä]] ÁÂÇÏ(¸ðµå)¹öÆ°...±âº»½Ã°£¸ðµå¿¡¼ Çѹø ´©¸£¸é ¿ùµåŸÀÓ, µÎº¯Â°´Â ¾Ë¶÷¸ðµå, ¼¼¹ø°´Â ŸÀ̸Ӹðµå, ³×¹ø°´Â ½ºÅé¿öÄ¡¸ðµå·Î ¹Ù²ñ
....´ë·«ÀûÀ¸·Î ¹öÆ°º° ±â´É ¼÷ÁöÇØ µÎÀÚ.. ¼ø¼´Â ¸ÕÀú [[Á»ó...±âº»½Ã°£°ü·Ã»çÇ× Á¶Á¤/ÀúÀå]], [[ÁÂÇÏ.....¸ðµå : ¿ùµåŸÀÓ/¾Ë¶÷/ŸÀ̸Ó/½ºÅé¿öÄ¡]], [[¿ì»ó...¶óÀÌÆ®]], [[¿ìÇÏ...½ºÅ¸Æ®/½ºÅé]]¹öÆ°À¸·Î¼ ¿ì»ó/ÇÏ ¹öÆ°Àº ¼ýÀÚ º¯°æ½Ã¿¡µµ ¾²ÀÓ.(¿ìÇϹöÆ°Àº ¼¼Æó»¿ëÀÇ ¿Â-¿ÀÇÁ Àû¿ë Á¶Àý¿¡µµ ¾²ÀÓ)
[[½Ã°£º¯°æ]]
---¿ä¾àÇϸé, ±âº»½Ã°£È¸éÀ» ¸®¼¼Æà À§Çؼ´Â Á»ó¹öÆ°À» ±æ°Ô ´·¯¼ Ãʽ𢿵¿ªÀ» Á¡¸ê½ÃŲÈÄ ¿ì»ó/ÇÏ ¹öÆ°À¸·Î ¼ýÀÚ Á¶Á¤ÇØ ÁÖ¾úÀ¸¸é ±×´ÙÀ½ ¼ø¼´Â [ÁÂÇÏ..¸ðµå]¸¦ ´·¯¼ Áö¿ª½á¸ÓŸÀÓ, ´Ù½Ã [[ÁÂÇÏ..¸ðµå]]¸¦ ´·¯¼ ¾¾Æ¼ÄÚµå(Áö¿ª½á¸ÓŸÀÓÀ» Àû¿ëÇÒÁö ¸»Áö´Â ¿ìÇÏ ¹öÆ°À¸·Î Á¶Á¤) , ´Ù½Ã [ÁÂÇÏ..¸ðµå]´·¯¼ ½Ã°£, ´Ù½Ã ºÐ, ´Ù½Ã ¿¬-¿ù-ÀÏ, ´Ù½Ã ¶óÀÌÆñⰣ ¼ø¼·Î ÇϳªÇϳª ¼¼ÆÃ(¼ýÀÚ ±³Á¤Àº ¿ì»ó/ÇϹöÆ° »ç¿ë), ±×ÈÄ ´Ù½Ã [ÁÂÇÏ..¸ðµå]¸¦ ´·¯ÁÖ¸é Ãʽ𢠿µ¿ª Á¡¸ê»óÅ·μ ±âº»½Ã°£ ȸéÀ¸·Î º¹±ÍµÇ´Âµ¥, ÀÌ´ë·Î [Á»ó...Á¶Á¤]À» ´©¸£¸é ÀúÀåµÇ¸é¼ Ãʽð¢ Á¡¸êÀÌ »ç¶óÁü.....±×·³, ÀÌÁ¦, ¼¼ÆÃÇØ º¸ÀÚ.
...±âº»½Ã°£¸ðµå»óÅ¿¡¼ [Á»ó..Á¶Á¤]¹öÆ°À» ±æ°Ô ´©¸£¸é Ãʽð£ Á¡¸ê»óÅ°¡ µÊ
...ÄÄÇ»ÅÍ/ÇÚµåÆùÀÇ Ãʽð£ÀÌ 00ÀÌ µÉ ¶§¸¦ ±â´Ù·Á¼ [¿ìÇÏ ¹öÆ°]À» ´©¸£¸é 00ÃÊ·Î ¸®¼¼ÆõÊ.
...[ÁÂÇÏ...¸ðµå]¹öÆ°À» ´©¸£¸é DST°¡ À§¿¡ OFF°¡ ¹Ø¿¡ ³ª¿È DST´Â Áö¿ª½á¸ÓŸÀÓ, ÀÌ°ÍÀÌ OFF»óŶó´Â ¶æ...(¿ìÇϹöÆ°À¸·Î on-off°¡´É...Çѱ¹Àº ½á¸ÓŸÀÓÀÌ ¾øÀ¸¹Ç·Î off ±×´ë·Î µÒ).
...±× ´ÙÀ½ ±âÁصµ½Ã(city code) ¼¼Æà À§ÇØ [¿ìÇÏ...¸ðµå]¸¦ ´©¸§(±âº»Àº Çѱ¹¼¿ï SEL.....¿ì»ó/ÇÏ ¹öÆ°À¸·Î À̵¿¼¼Æà °¡´ÉÇѵ¥..±×´ë·Î µÒ).
...±× ´ÙÀ½Àº ½Ã°£ ¼¼ÆÃÀ» À§ÇØ [ÁÂÇÏ..¸ðµå]¹öÆ° ´©¸§...(½Ã°£¿µ¿ªÀÌ Á¡¸êµÇ°í ¿ì»ó/ÇÏ ¹öÆ°À¸·Î ¼ýÀÚ ¼¼ÆÃ...ÇöÀç½Ã°£°ú µ¿ÀÏÇÏ°ÔÇÒ °Í...¿ÀÈĶó¸é PMÀÌ ³ª¿Àµµ·Ï ¼ýÀÚ¸¦ Á¶Á¤ÇÑ´Ù).
...ÀÌÁ¦´Â ºÐ ¼¼Æà À§ÇØ ´Ù½Ã [ÁÂÇÏ..¸ðµå]¹öÆ° ´©¸£¸é Á¡¸êÀÌ ºÐ ¿µ¿ªÀ¸·Î À̵¿(µ¿ÀÏÇÑ ¹æ¹ýÀ¸·Î ¿ìÃø»ó/ÇÏ ¹öÆ°À» ÀÌ¿ëÇؼ ºÐ ¼¼ÆÃ).
...±×ÈÄ 12H¶Ç´Â 24½Ã ½Ã½ºÅÛÁß Çϳª¸¦ ¼±ÅÃÇØ Áִµ¥, ¿ª½Ã [ÁÂÇÏ...¸ðµå] ¹öÆ°À» ´·¯ÁÜ....(º¸Åë12H¸¦ »ç¿ë).
...±× ÈÄ ³âµµ¼¼Æà À§ÇØ ¿ª½Ã [ÁÂÇÏ..¸ðµå]¹öÆ° ´©¸£¸é ¿¬µµ°¡ ¶ß´Âµ¥, ÀÌ ¿ª½Ã ¿ì»ó/ÇÏ ¹öÆ°À¸·Î ¼ýÀÚ¸¦ ±³Á¤.
...±×´ÙÀ½¿£, ¿ù/ÀÏ ±³Á¤Àε¥ ¿ª½Ã [ÁÂÇÏ...¸ðµå]¹öÆ° ´©¸¥ ÈÄ ¿ì»ó/ÇÏ ¹öÆ°À¸·Î ¼ýÀÚ¸¦ ±³Á¤ÇÔÀ¸·Î½á °¡´É.
...±× ´ÙÀ½Àº ¶óÀÌÆý𣠼¼ÆÃÀε¥, [ÁÂÇÏ..¸ðµå]¸¦ ´·¯ÁÖ°í ¿ì»ó/ÇϹöÆ°À¸·Î ±³Á¤(1-3, Áï 1-3Ãʸé Àû´ç).
...ÀÌÁ¦ ´Ù½Ã [ÁÂÇÏ...¸ðµå]¹öÆ°À» ´©¸£¸é ÃÖÃÊ ½ÃÀÛÇß´ø ±âº»½Ã°£È¸éÀ¸·Î º¹±ÍµÈ »óÅ¿¡¼ ÃÊ¿µ¿ª¸¸ Á¡¸êÇÏ°Ô µÊ.... À̶§, [Á»ó....Á¶Á¤]¹öÆ° ´·¯ÁÖ¸é Á¡¸êÀÌ »ç¶óÁö¸é¼ ÀúÀåµÊ
[[¾Ë¶÷¼³Á¤]]
±âº»½Ã°£¸ðµå»óÅ¿¡¼ [ÁÂÇÏ..¸ðµå]¹öÆ° 2¹ø ´·¯ ¾Ë¶÷¸ðµå ¶ç¿ò(¾Ë¶÷¸ðµå ±âº» ȸéÀº 12:00-1).....ÀÌ »óÅ¿¡¼ [¿ìÇϹöÆ°]À» ¿©·¯¹ø ´·¯º¸¸é-1¿¡¼-5±îÁö ³ª¿À°í(Áï, 5°³±îÁö ¼¼Æð¡´ÉÇÏ´Ù´Â ¶æ) ±×ÈÄ 00ÀÌ ³ª¿À´Âµ¥, ÀÌ´Â ½Ãº¸¸¦ ¶æÇÔ....¿ìÇϹöÆ°À» Çѹø ´õ ´·¯¼ 12:00-1·Î ´Ù½Ã µ¹¾Æ°¨.
...ÀÌÁ¦ 1¹ø¼¼ÆÃÀ» ½ÃµµÇØ º¸ÀÚ....12:00-1 »óÅ¿¡¼ [Á»ó, Á¶Á¤]À» ±æ°Ô ´·¯ÁÖ¸é ½Ã°£¿µ¿ªÀÌ Á¡¸ê»óÅ°¡ µÊ....¿ì»ó/ÇÏ ¹öÆ°À¸·Î ¿øÇÏ´Â ½Ã°£À» ¼³Á¤..
...±×ÈÄ ÁÂÇÏ ¹öÆ° ´©¸£¸é ºÐ¿µ¿ªÀ¸·Î Á¡¸ê»óÅ°¡ À̵¿µÊ, µ¿ÀÏÇÏ°Ô ¿ì»ó/ÇÏ ¹öÆ°À¸·Î ºÐÀ» ¼³Á¤.
...±×ÈÄ ÁÂÇϹöÆ°À» ´·¯¼ ¾Ë¶÷ŸÀÓÈ¿°ú ±â°£À» ¼³Á¤ °¡´É...¿ìÇϹöÆ°À» ´·¯º¸¸é 1-on°ú onÀÌ ¹ø°¥¾Æ ¹Ù²ñ....(1-onÀº ¼³Á¤´çÀϸ¸ ¾Ë¶÷ ¿ï¸®°í, onÀº ¸ÅÀÏ ±× ½Ã°£¿¡ ¿ï¸²)....¼±ÅÃÀÌ ³¡³µÀ¸¸é ÀÌÁ¦ [Á»ó...Á¶Á¤¹öÆ°]À» ´©¸£¸é Á¡¸êÀÌ ÇØÁ¦µÇ¸é¼ ¼¼Æó»¿ëÀÌ ÀúÀåµÊ...
***¾Ë¶÷ ½Ã°£ on/off ¼±ÅÃ... ¾Ë¶÷¸ðµå ¸¸µçÈÄ ¿ìÇϹöÆ°À¸·Î Á¶Á¤ÇÏ·Á´Â ¾Ë¶÷½Ã°£(-1ºÎÅÍ -5±îÁö 5°³Áß)À» ¼±ÅÃÇÑ ÈÄ [Á»ó...Á¶Á¤]¹öÆ°À» ª°Ô ´·¯ÁÖ¸é ´©¸¦ ¶§ ¸¶´Ù on/off¼±ÅÃÀÌ °¡´É...¿Ç°Ô ¼±ÅÃÇßÀ¸¸é [Á»ó...Á¶Á¤]¹öÆ° ´·¯¼ ºüÁ®³ª¿È..
=====ÅðÁ÷±Ý°è»ê=====
**ÅðÁ÷±Ý °è»ê : 3°³¿ù°£ ÀÓ±ÝÃÑ¾× ÷ 3°³¿ù°£ÀÇ ÀϼöÇÕ = 1ÀÏ Æò±ÕÀÓ±Ý....... 1ÀÏ Æò±ÕÀÓ±Ý × 30ÀÏ × ÀçÁ÷Àϼö ÷ 365ÀÏ
=====¸éÇã½Å°í=======
**¸éÇã½Å°í : ½ÃµµÀÇ»çȸ»çÀÌÆ®¿¡¼ Á÷Á¢ ¤º¸®ÇÔ...±×·¯³ª, ÀÏ´Ü ÀÇÇù·Î±×ÀÎ(yk@1yk2)Çؼ ½Å°í±â°£ Á÷Àü3³â°£ÀÇ ¿¬¼öÃÑÁ¡ÀÌ24Á¡ÀÌ»ó(±×Áß ½ÃµµÀÇ»çȸÇʼöÆòÁ¡¸Å³â2Á¡¾¿ Æ÷ÇÔ)È®º¸»óȲ ¹× ¿¬È¸ºñ³³ºÎ󸮿Ϸá È®ÀÎÇÑ ÈÄ, ½ÃµµÀÇ»çȸ»çÀÌÆ®¿¡ ·Î±×ÀÎ(yk_kky04k07)Çؼ ¸éÇã½Å°íȸ鿡¼ ±âÁ¸½Å°í³»¿ëÁß ±âÀ纯µ¿ÇÊ¿ä»çÇ×ÀÌ ÀÖ´ÂÁö¸¦ È®ÀÎÇÑ ´ÙÀ½ µî·ÏÇÒ °Í.(ÃÖ±Ù ½Å°í¿¬µµ´Â 2019)..¸éÇã½Å°íºñ¹ø ±â¾ï¾È³ª¸é ÀÇÇù¸éÇã½Å°í02/63506610¿¡ ¹®ÀÇ. |